Johnson & Johnson - 63 Year Stock Price History | JNJ
Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of May 30, 2025 is 155.21.
- The all-time high Johnson & Johnson stock closing price was 168.80 on April 25, 2022.
- The Johnson & Johnson 52-week high stock price is 169.99, which is 9.5% above the current share price.
- The Johnson & Johnson 52-week low stock price is 140.68, which is 9.4% below the current share price.
- The average Johnson & Johnson stock price for the last 52 weeks is 155.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data |
Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
2025 |
153.7264 |
141.6640 |
166.2770 |
139.7360 |
155.2100 |
9.11% |
2024 |
150.5325 |
152.5250 |
163.3320 |
138.7730 |
142.2550 |
-4.81% |
2023 |
150.4521 |
164.8930 |
166.7990 |
137.7210 |
149.4450 |
-8.58% |
2022 |
157.5496 |
154.6750 |
168.7990 |
143.5080 |
163.4680 |
5.98% |
2021 |
147.3126 |
137.6450 |
159.8230 |
135.4680 |
154.2510 |
11.44% |
2020 |
126.4814 |
124.9860 |
138.4190 |
95.7697 |
138.4190 |
10.82% |
2019 |
113.8616 |
106.3860 |
125.3880 |
104.6960 |
124.9000 |
16.22% |
2018 |
109.2594 |
112.8840 |
123.1170 |
98.1493 |
107.4690 |
-5.13% |
2017 |
103.8781 |
91.5419 |
115.8520 |
88.3177 |
113.2820 |
24.43% |
2016 |
88.5700 |
77.2213 |
97.7644 |
73.5862 |
91.0441 |
15.33% |
2015 |
75.5193 |
78.0140 |
80.8871 |
69.2179 |
78.9428 |
1.14% |
2014 |
74.2524 |
66.1120 |
80.9996 |
62.9092 |
78.0513 |
17.34% |
2013 |
61.3912 |
49.9322 |
69.4528 |
49.8617 |
66.5187 |
34.62% |
2012 |
46.3230 |
44.7793 |
50.6683 |
42.7758 |
49.4106 |
10.85% |
2011 |
42.4021 |
41.2000 |
45.3374 |
38.1578 |
44.5753 |
9.89% |
2010 |
40.0204 |
40.9743 |
42.1496 |
36.7306 |
40.5638 |
-0.59% |
2009 |
36.0280 |
37.1734 |
41.1517 |
28.7988 |
40.8033 |
11.27% |
2008 |
39.1830 |
39.2668 |
43.9000 |
33.9127 |
36.6708 |
-7.72% |
2007 |
37.6180 |
38.5730 |
40.7503 |
35.0580 |
39.7375 |
3.61% |
2006 |
35.7181 |
34.9791 |
39.9160 |
32.2377 |
38.3522 |
12.43% |
2005 |
36.3430 |
35.0076 |
38.7924 |
34.0766 |
34.1107 |
-3.36% |
2004 |
30.8179 |
28.1986 |
35.4862 |
27.1387 |
35.2970 |
25.17% |
2003 |
28.4442 |
29.6648 |
31.5850 |
26.4724 |
28.1986 |
-2.08% |
2002 |
30.6850 |
31.0477 |
34.7467 |
22.2796 |
28.7962 |
-7.88% |
2001 |
27.3428 |
26.8059 |
32.2484 |
21.8783 |
31.2593 |
13.21% |
2000 |
23.4599 |
24.2271 |
27.6107 |
18.0020 |
27.6107 |
12.67% |
1999 |
24.7116 |
21.7305 |
27.8899 |
20.2358 |
24.5063 |
11.18% |
1998 |
19.7158 |
17.0986 |
23.3894 |
16.8193 |
22.0425 |
27.32% |
1997 |
15.6754 |
13.0744 |
17.5913 |
13.0744 |
17.3121 |
32.41% |
1996 |
12.7632 |
11.0705 |
14.1256 |
11.0048 |
13.0744 |
16.37% |
1995 |
9.0432 |
7.1613 |
12.0232 |
7.0628 |
11.2348 |
56.16% |
1994 |
6.0702 |
5.9458 |
7.3256 |
4.8289 |
7.1942 |
22.01% |
1993 |
5.5181 |
6.5043 |
6.5043 |
4.6811 |
5.8966 |
-11.14% |
1992 |
6.4855 |
7.3748 |
7.6458 |
5.6666 |
6.6357 |
-11.79% |
1991 |
5.8899 |
4.5989 |
7.5883 |
4.3115 |
7.5226 |
59.58% |
1990 |
4.1289 |
3.9337 |
4.8207 |
3.4163 |
4.7139 |
20.84% |
1989 |
3.2884 |
2.7470 |
3.9009 |
2.7470 |
3.9009 |
39.50% |
1988 |
2.6598 |
2.5663 |
2.8948 |
2.2831 |
2.7963 |
13.69% |
1987 |
2.8312 |
2.2132 |
3.4369 |
2.1188 |
2.4596 |
14.09% |
1986 |
2.0929 |
1.7041 |
2.4268 |
1.5686 |
2.1558 |
24.71% |
1985 |
1.4631 |
1.1703 |
1.7985 |
1.1538 |
1.7287 |
45.67% |
1984 |
1.1264 |
1.3427 |
1.3920 |
0.9280 |
1.1867 |
-11.62% |
1983 |
1.5001 |
1.6261 |
1.6794 |
1.2893 |
1.3427 |
-17.64% |
1982 |
1.3417 |
1.2031 |
1.6753 |
1.0676 |
1.6302 |
33.68% |
1981 |
1.1221 |
1.0936 |
1.2647 |
0.9362 |
1.2195 |
11.66% |
1980 |
0.8690 |
0.8404 |
1.0950 |
0.7282 |
1.0922 |
25.87% |
1979 |
0.7896 |
0.8130 |
0.8760 |
0.7090 |
0.8677 |
7.44% |
1978 |
0.8403 |
0.8212 |
0.9718 |
0.7213 |
0.8076 |
-3.90% |
1977 |
0.7704 |
0.8554 |
0.8554 |
0.6857 |
0.8404 |
-1.60% |
1976 |
0.9454 |
0.9868 |
1.0525 |
0.7884 |
0.8541 |
-13.09% |
1975 |
0.9741 |
0.9088 |
1.0840 |
0.8076 |
0.9827 |
10.96% |
1974 |
1.0793 |
1.2236 |
1.3017 |
0.8226 |
0.8856 |
-28.27% |
1973 |
1.3016 |
1.4071 |
1.4290 |
1.1443 |
1.2346 |
-13.60% |
1972 |
1.2913 |
1.0704 |
1.4467 |
1.0389 |
1.4290 |
32.49% |
1971 |
0.9320 |
0.6269 |
1.0827 |
0.6269 |
1.0786 |
72.82% |
1970 |
0.5633 |
0.6406 |
0.6488 |
0.4092 |
0.6241 |
-5.01% |
1969 |
0.4665 |
0.3860 |
0.6570 |
0.3695 |
0.6570 |
69.02% |
1968 |
0.3229 |
0.3285 |
0.3887 |
0.2728 |
0.3887 |
16.06% |
1967 |
0.2795 |
0.2056 |
0.3495 |
0.2020 |
0.3349 |
61.01% |
1966 |
0.2114 |
0.2129 |
0.2433 |
0.1702 |
0.2080 |
-0.76% |
1965 |
0.1689 |
0.1353 |
0.2123 |
0.1353 |
0.2096 |
54.12% |
1964 |
0.1278 |
0.1270 |
0.1448 |
0.1168 |
0.1360 |
9.59% |
1963 |
0.1093 |
0.0909 |
0.1443 |
0.0903 |
0.1241 |
39.28% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Large Cap Pharmaceutical |
$373.447B |
$88.821B |
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|